Literature DB >> 11480226

Effect of fluvoxamine and N-methyl-D-aspartate receptor antagonists on shock-induced depression in mice.

H K Chaturvedi1, J S Bapna, D Chandra.   

Abstract

We have earlier demonstrated that NMDA receptor antagonists possess antidepressant effect and also they show a synergism with imipramine. The present study attempts to investigate whether NMDA receptor antagonists also interact with selective serotonin reuptake inhibitors. The study was conducted in albino mice using shock-induced depression model. The mice were placed on a grid floor and shock delivered were of 2 sec duration with a 9 sec interval for 1 h. Twenty four hours later depression was measured by an open field test followed by a forced swimming test. Presentation of inescapable foot shock significantly reduced ambulation (from 159.50 +/- 5.42 to 80.50 +/- 4.61) and rearing (from 22.10 +/- 2.15 to 11.30 +/- 1.32) in the open field arena and increased immobility duration in the forced swimming test (from 82.20 +/- 3.51 to 158.90 +/- 4.61). Pretreatment with fluvoxamine, MK-801, ketamine and the combination of fluvoxamine with either of the NMDA antagonists antagonised shock-induced depression. Haloperidol and ketanserin pretreatment modified the effect of these agents. These findings suggest an interaction of NMDA receptor antagonists with fluvoxamine, and an involvement of brain dopaminergic and tryptaminergic mechanisms in the behavioural suppression observed after inescapable foot shock.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11480226

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  7 in total

1.  Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Tanara V Peres; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  J Neural Transm (Vienna)       Date:  2017-07-10       Impact factor: 3.575

2.  Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study.

Authors:  Eric J Lenze; Elizabeth R Skidmore; Amy E Begley; John W Newcomer; Meryl A Butters; Ellen M Whyte
Journal:  Int J Geriatr Psychiatry       Date:  2011-12-16       Impact factor: 3.485

3.  Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Authors:  Sanjay J Mathew; James W Murrough; Marije aan het Rot; Katherine A Collins; David L Reich; Dennis S Charney
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-17       Impact factor: 5.176

Review 4.  Factors influencing behavior in the forced swim test.

Authors:  Olena V Bogdanova; Shami Kanekar; Kristen E D'Anci; Perry F Renshaw
Journal:  Physiol Behav       Date:  2013-05-14

5.  Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs.

Authors:  Silvia L Cruz; Paulina Soberanes-Chávez; Nayeli Páez-Martinez; Carolina López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  2009-01-17       Impact factor: 4.530

6.  MicroRNA expression profile and functional analysis reveal that miR-206 is a critical novel gene for the expression of BDNF induced by ketamine.

Authors:  Xiaolin Yang; Qinyan Yang; Xiaobin Wang; Chunqiong Luo; Yunqiang Wan; Jiali Li; Kezhi Liu; Min Zhou; Chunxiang Zhang
Journal:  Neuromolecular Med       Date:  2014-05-18       Impact factor: 3.843

Review 7.  Neuroplasticity and the next wave of antidepressant strategies.

Authors:  Shawn Hayley; Darcy Litteljohn
Journal:  Front Cell Neurosci       Date:  2013-11-20       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.